The Supreme Court of India has taken notice of the spiralling cost of medical treatment in India. It directed the government to ‘do something’ as the common man is unable to get the required treatment owing to the ‘huge cost’
These remarks hold major significance as they come on the lines of National Pharmaceutical Pricing Authority (NPPA) recent letter which said that non-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals in Delhi and national capital region (NCR) with margins as high as 1,192 per cent.
According to the analysis carried out by the NPPA, the margin on procurement price of drugs used in emergency cases for treatment of potentially life-threatening low blood pressure was 1,192 per cent.
The drug pricing regulator had recently said that in case of Adrenor 2 ml injection with an MRP of Rs 189.95, the purchase price for the hospitals was Rs 14.70 but the patients were being charged Rs 5,318.60, including taxes.
The top court’s remark came as it asked the Centre whether any study has been conducted on the effects of air pollution on the health of people and the amounts spent on medical treatment of such ailments.
The apex court had earlier asked the Centre to look into the issue of air pollution on a nationwide basis and not confine it only to Delhi-NCR, saying it was a problem concerning the entire country.
The court was hearing a PIL filed in 1985 by environmentalist M C Mehta who had raised the issue of air pollution in the Delhi-NCR.